Skip to content
Events

Details

In this webinar, we expand on how the innovations of NovaSeq X are making multiomics a reality. We will highlight data from multi-project runs, massive single cell and CRISPR applications, and developing a protocol for liquid biopsy.
Speakers
Meghan Buckley,

Meghan Buckley, PhD
Product Marketing Manager
Illumina

Robert Yamulla

Robert Yamulla, PhD, MBA
Research Applications Marketing Lead
Illumina

M-AMR-01589
Fill Out Form to Access Webinar

Your email address is never shared with third parties.

Date & Time
9 Oct. 2024
Presenter
Meghan Buckley
Robert Yamulla
Topic
Instruments, Software & informatics, Sequencing reagents & flow cells
Watch Now

Related Events

Apr 2
Bio-IT World Conference & Expo 2025
Apr 2, 2025 – Apr 4, 2025
Visit Illumina booth 704 to learn about the latest advancements in multiomics discovery.
View Event
Apr 9
How Can AI and Automation Boost Cytogenetic Array Analysis Efficiencies?
Apr 9, 2025
Labs face increasing challenges with variant knowledge, sample volume, and evolving assay needs, all while maintaining operational and cost efficiencies. This 20-minute webinar and live demo will show how bioinformatic solutions can streamline data analysis and interpretation in array clinical research workflows.
View Event
May 5
APHL 2025 Annual Conference
May 5, 2025 – May 8, 2025
APHL 2025 is a conference for the public health​ laboratory community, bringing together leaders, scientists, influencers and partners to share issues, trends, and best practices driving laboratory science and public health today.
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see sapac.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.